2022_HCmed_Skyscraper1

2023_Technolution_Leaderboard

CONNECTIVITY

TAKING A PATIENT-CENTRIC APPROACH TO CANCER CARE THROUGH IMMUNOTHERAPY

Corinne Fechant and Laura Hilliquin highlight the role digital health solutions can play in supporting patient self-administration for the increasing number of immunotherapies for cancer treatment.

LESSONS FROM MARKETED MEDICAL DEVICES TO ENHANCE CONNECTED DRUG DELIVERY

Fallyn Flaherty-Earp looks at what medical device manufacturers can learn from connected devices already on the market and discusses the opportunities electronic inks can provide for the development of innovative therapies for the treatment of chronic diseases.

Technology Showcase: CCBio’s Felice Dose – Simplifying Subcutaneous Infusion

Technology Showcase: CCBio’s Felice Dose – Simplifying Subcutaneous Infusion

CCBio showcases Felice Dose, a revolutionary on-body injector (OBI) designed to address the challenges of traditional IV injections and SC drug administration.

Interview with Julien Martins & David Philbrick

Paragon Medical

Interview with Julien Martins & David Philbrick

Julien Martins and David Philbrick talk exclusively with ONdrugDelivery's Guy Furness. They discuss a wide range of topics, including the services Paragon Medical provides the drug delivery industry, its wider business operations, the company’s expanded facilities in the US and Europe, and its new Advanced Surgical Innovation Center.

RFID-BASED UNIT-LEVEL TRACEABILITY: COULD IT BE THE KEY TO OPERATIONAL EXCELLENCE FOR FILL-FINISH LINES?

INDUSTRIALISATION

BD (Becton Dickinson & Company)

RFID-BASED UNIT-LEVEL TRACEABILITY: COULD IT BE THE KEY TO OPERATIONAL EXCELLENCE FOR FILL-FINISH LINES?

Yacine Haddadi and Herve Soukiassian look at how the company’s track & trace model can help manufacturers improve their fill-finish operations.

CONNECTING PHARMA: INSIGHTS FROM AUTOMOTIVE INDUSTRY EXPERIENCE

EdgeOne Medical

CONNECTING PHARMA: INSIGHTS FROM AUTOMOTIVE INDUSTRY EXPERIENCE

Jim McGough talks with Guy Furness about the current state and future of connectivity in drug delivery and pharma more broadly. In an enlightening discussion, Mr McGough shares insights from his time pioneering connectivity in the automotive industry at Volkswagen Group and how those lessons might apply to pharma, as well as considering what might be holding the industry back from going full steam ahead on connectivity and how that might change over the next decade.

DIGITAL TWIN IN THE PHARMACEUTICAL SUPPLY CHAIN

DIGITAL TWIN IN THE PHARMACEUTICAL SUPPLY CHAIN

Gerresheimer’s Ali Badiei explains the role of digital twin technology and its integration into the pharmaceutical supply chain, highlighting an innovative approach to ensuring drug identity and quality.

REIMAGINING AUTOINJECTOR CONNECTIVITY

Dr Kate Hudson-Farmer

REIMAGINING AUTOINJECTOR CONNECTIVITY

Kate Hudson-Farmer and Simon Hall discuss a new smartphone-based connectivity solution for autoinjectors that requires no additional hardware and works with most autoinjectors and smartphones.

Real-World Evidence in the Age of Digital Health – Unlocking Value for Pharmaceutical Companies

Ventsislav Dobrev

Real-World Evidence in the Age of Digital Health – Unlocking Value for Pharmaceutical Companies

Ventsislav Dobrev, Philippe Müller and Rafael Weiler explore how real-world evidence in the age of digital health can help unlock value for pharmaceutical companies.

EMPOWERING PATIENTS FOR SELF-CARE WITH NFC CONNECTIVITY

NXP Semiconductors

EMPOWERING PATIENTS FOR SELF-CARE WITH NFC CONNECTIVITY

Sylvia Kaiser-Kershaw looks at how near-field communication technology can be used to add connectivity to medical devices, empowering patients to self-administer medication.

Interview with Arnaud Guillet & Fanny Sellier

Interview with Arnaud Guillet & Fanny Sellier

Arnaud Guillet and Fanny Sellier talk with Guy Furness about how Biocorp has become a key player in the field of connected drug delivery, discuss the current landscape for connectivity in drug delivery and update us on its two major parenteral products – Mallya and Injay – as well as looking forward to the launch of the company’s next generation of connected drug delivery solutions.

THE POTENTIAL OF CONNECTIVITY AND MONITORING IN MESH NEBULISERS

Carolina Dantas

THE POTENTIAL OF CONNECTIVITY AND MONITORING IN MESH NEBULISERS

Carolina Dantas and Ulf Krueger review the current connectivity and remote monitoring capabilities in mesh nebulisers – and their potential to impact patients’ healthcare journeys and the clinical development of inhaled therapies.

COLLABORATIVE INNOVATION IN CONNECTED AUTOINJECTORS: HIGH-IMPACT ADHERENCE SOLUTIONS

Chelsea Williams

COLLABORATIVE INNOVATION IN CONNECTED AUTOINJECTORS: HIGH-IMPACT ADHERENCE SOLUTIONS

Chelsea Williams, Nils Weber and Gene Rhode Fuensalida Pantig discuss the potential of collaborative innovation in connected drug delivery when it comes to creating high-impact, low-touch adherence solutions.

THE IRONIES OF AUTOMATION: LESSONS FOR REMOTE PATIENT MONITORING

THE IRONIES OF AUTOMATION: LESSONS FOR REMOTE PATIENT MONITORING

Dan Lock considers how to overcome potential pitfalls and make the most of remote patient monitoring for the benefit of both patient care and clinical trials.

HARNESSING HUMAN FACTORS IN CONNECTED DEVICE DEVELOPMENT

HARNESSING HUMAN FACTORS IN CONNECTED DEVICE DEVELOPMENT

Finola Austin looks at the role human factors testing plays in the development of connected drug delivery devices.

BEYOND THE EYEDROPPER BOTTLE – THREE WAYS TO IMPROVE ADHERENCE

Dr Nathan Wilkinson

BEYOND THE EYEDROPPER BOTTLE – THREE WAYS TO IMPROVE ADHERENCE

Nathan Wilkinson, Catherine Wyman and Matt Parker discuss the future outlook of ophthalmic drug delivery beyond the traditional eyedropper bottle, including new delivery technologies, sustained-release therapeutics and digital healthcare applications.

Pharmapack Expert Panel on Patient-Centric Digital Health: Interview with Ben Cox, Team Consulting

Team Consulting

Pharmapack Expert Panel on Patient-Centric Digital Health: Interview with Ben Cox, Team Consulting

With Pharmapack returning to its traditional February timing in 2023, Team Consulting will be chairing a Day 1 expert panel discussion on patient-centric digital health solutions. Interviewed here, Ben Cox provides insight into trends the panel will discuss, lays out the current status of the industry with respect to digital health and considers what to look forward to at Pharmapack this year.

DESIGNING EFFECTIVE AND ENGAGING DIGITAL SOLUTIONS TO DRIVE ADHERENCE

Florian Krummenacher

DESIGNING EFFECTIVE AND ENGAGING DIGITAL SOLUTIONS TO DRIVE ADHERENCE

Florian Krummenacher and Philippe Müller discuss the effectiveness of combining connected injection devices with digital solutions to drive therapy outcomes.

CONNECTED DRUG DELIVERY DEVICES: BENEFITS AND CYBERSECURITY

João Budzinski

CONNECTED DRUG DELIVERY DEVICES: BENEFITS AND CYBERSECURITY

João Budzinski discusses the benefits of connected drug delivery devices and the importance of cybersecurity when developing them, including the threats, key considerations and potential solutions.

PATIENT JOURNEY AS THE FOUNDATION FOR HOLISTIC CONNECTED DEVICE DEVELOPMENT

PATIENT JOURNEY AS THE FOUNDATION FOR HOLISTIC CONNECTED DEVICE DEVELOPMENT

Mark Tunkel and Cécile Gross consider the development of connected drug delivery devices and identify how understanding the patient journey from diagnosis to treatment can be used as an early-stage decision-making tool.

BUILDING DIGITAL SOLUTIONS TO MEET THE UNIQUE THERAPEUTIC NEEDS OF PATIENTS

Benjamin D’hont

BUILDING DIGITAL SOLUTIONS TO MEET THE UNIQUE THERAPEUTIC NEEDS OF PATIENTS

Benjamin D’hont and Joe Reynolds discuss how the key to maturing the digital health market and increasing user retention of digital health apps is integrating agile app development from the beginning of a therapeutic’s development cycle.

Connected Drug Delivery – Is the Near-Term Opportunity in Clinical Development? – an Interview with Oliver Eden

Jabil Healthcare

Connected Drug Delivery – Is the Near-Term Opportunity in Clinical Development? – an Interview with Oliver Eden

Oliver Eden of Jabil Healthcare looks at the factors influencing the return on investment metrics in clinical development and introduces Jabil’s autoinjector platform Qfinity™ and its connected version, Qfinity+™.

ADVANCEMENTS IN MONITORING ADHERENCE – A SMART MESH NEBULISER

Edgar Hernan Cuevas Brun

HCmed Innovations

ADVANCEMENTS IN MONITORING ADHERENCE – A SMART MESH NEBULISER

Edgar Hernan Cuevas Brun and Yuan-Ming Hsu consider patient adherence and the role HCmed Innovations’ AdheResp mesh nebuliser plays in monitoring adherence.

DIGITAL HEALTH: ADDRESSING MODERN HEALTHCARE CHALLENGES WITH SENSORS

Dr Haykel Ben Jamaa

DIGITAL HEALTH: ADDRESSING MODERN HEALTHCARE CHALLENGES WITH SENSORS

Haykel Ben Jamaa explores why modern society needs digital health and how it is organised and implemented, with a focus on sensing technologies empowering digital health technologies.

AREAS TO WATCH IN CONNECTED DRUG DELIVERY DEVICE DEVELOPMENT

AREAS TO WATCH IN CONNECTED DRUG DELIVERY DEVICE DEVELOPMENT

Michael Earl identifies areas of development in the field of connected drug delivery devices, providing an insight into what can be expected in the coming years. He draws on Owen Mumford’s own research, as well as discussions with industry experts and counterparts.

COULD VIVERA BE THE NEXT MEDTECH UNICORN START-UP?

Amanda Whitcroft

Vivera Pharmaceuticals

COULD VIVERA BE THE NEXT MEDTECH UNICORN START-UP?

Few technology companies reach unicorn status. US medtech company Vivera is hoping to be the next one, with its innovative approach to prescription drug delivery that aims to increase patient adherence and stop prescription drug abuse.

CONSIDERING THE SUSTAINABILITY IMPACT OF CONNECTED INHALERS IN THE TREATMENT OF ASTHMA

Dr Iain Simpson

Phillips-Medisize

CONSIDERING THE SUSTAINABILITY IMPACT OF CONNECTED INHALERS IN THE TREATMENT OF ASTHMA

Iain Simpson and Vinith Bhandari consider the sustainability impact of device connectivity specific to asthma inhalers through the reduction of greenhouse gas emissions.

Interview with Biocorp’s Arnaud Guillet

Interview with Biocorp’s Arnaud Guillet

In this exclusive interview, Arnaud Guillet of Biocorp talks with ONdrugDelivery about connectivity in the injectables space, sharing some of the insights Biocorp has gained from its decade of experience in developing connected drug delivery devices.

Technology Showcase: Investigation into the Feasibility of a 2 mL Needle-Free Injector

Portal Instruments

Technology Showcase: Investigation into the Feasibility of a 2 mL Needle-Free Injector

Portal Instruments showcases its Prime needle-free drug delivery platform, and makes the case that there is a significant opportunity to transform the patient experience with a reusable and connected needle-free injector.

Technology Showcase: I-Platform from CCBio – How to Upgrade a Device in One Platform

Technology Showcase: I-Platform from CCBio – How to Upgrade a Device in One Platform

CCBio showcases its I-Platform injectable drug delivery solution comprising: delivery units, including the electronic, connected Tesla device; containers and adapters; and safety needles.

OFFERING A SMART AND SUSTAINABLE ON-BODY INJECTOR FOR CHRONICALLY ILL PATIENTS

OFFERING A SMART AND SUSTAINABLE ON-BODY INJECTOR FOR CHRONICALLY ILL PATIENTS

Cécile Gross discusses the unmet drug delivery needs in chronic diseases, and details how Nemera’s answer – the Symbioze^® on-body injector – fulfils these needs.

TURNING CONNECTED DRUG DELIVERY PIPE DREAMS INTO REALITY

TURNING CONNECTED DRUG DELIVERY PIPE DREAMS INTO REALITY

Mindy Katz discusses the benefits of integrating homecare technologies that are patient centric and connected.

MEETING AN UNMET PHARMA NEED: PIONEERING THE WAY TO A CONNECTED FUTURE

Chelsea Williams

MEETING AN UNMET PHARMA NEED: PIONEERING THE WAY TO A CONNECTED FUTURE

Chelsea Williams, Nagisa Kobashi and Nils Weber discuss the digital transformation of injectables, where drug formulation and device are enmeshed within a connected ecosystem powered by patient data.

A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED CLINICAL TRIALS – THE HUMAN FACTORS RESULTS ARE IN!

BD (Becton Dickinson & Company)

A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED CLINICAL TRIALS – THE HUMAN FACTORS RESULTS ARE IN!

Aurélie Pager and Mircea Despa follow up on an article published in the December 2021 issue of ONdrugDelivery. BD has now completed a human factors study assessing the usability, acceptance and ease of use of its connected injection prototype for clinical trials.

PAVING THE WAY TO INTEGRATED DEVICE-DIGITAL SOLUTIONS

Dr Andreas Schneider

PAVING THE WAY TO INTEGRATED DEVICE-DIGITAL SOLUTIONS

Andreas Schneider and Philippe Müller discuss the potential benefits and challenges of implementing connected device-digital solutions within the healthcare sector to improve the treatment of chronic conditions.

FOCUS ON ADHERENCE TO EMBRACE DCT BENEFITS

Dr Bernard Vrijens

FOCUS ON ADHERENCE TO EMBRACE DCT BENEFITS

Bernard Vrijens looks at the effect of decentralised clinical trials on medication adherence in clinical studies.

CONNECTING PATIENTS AND HEALTHCARE PROVIDERS IN THE AGE OF SELF-ADMINISTERED INJECTABLE DRUGS

Bespak by Recipharm

CONNECTING PATIENTS AND HEALTHCARE PROVIDERS IN THE AGE OF SELF-ADMINISTERED INJECTABLE DRUGS

Gemma Wood explores connected device development trends, the patient-centric benefits the technology has to offer and how, with the help of experienced manufacturing partners connected to key enabling technology partners, they can develop products that deliver improved patient outcomes.

A GAME CHANGER FOR HIGH-RISK MEDICATIONS VIA AN INTRANASAL DELIVERY PLATFORM

A GAME CHANGER FOR HIGH-RISK MEDICATIONS VIA AN INTRANASAL DELIVERY PLATFORM

Marcel Botha, Andreas Bilstein, Houssam Elghobary and Rouven Kraus discuss the benefits of the Validose digital health platform for the safe delivery of high-value and/or high-risk products.

1
2
3
…
9
Next

Top